Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.
Morioka H, Takahashi S, Araki N, Sugiura H, Ueda T, Takahashi M, Yonemoto T, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Susa M, Nakayama R, Nishimoto K, Kikuta K, Horiuchi K, Kawai A.
Morioka H, et al. Among authors: araki n.
BMC Cancer. 2016 Jul 14;16:479. doi: 10.1186/s12885-016-2511-y.
BMC Cancer. 2016.
PMID: 27418251
Free PMC article.
Clinical Trial.